We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Amino Acid Profile in the Fetus and the Neonate

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by Sheba Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01140698
First Posted: June 9, 2010
Last Update Posted: June 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose

Up-to-date, the preterm newborn nutrition is based on human breast milk or it's imitations. However, the growth rate is known to be reduced compared to the fetal growth rate. In order to attempt a better growth rate of the preterm newborn infants it is important to evaluate the metabolic components of the fetal blood and try to find components that might influence its growth.

Little is known of the metabolic components of the fetal blood, including amino acid profile. The aim of the study is to evaluate amino acid profile in the fetus blood in different gestational ages and compare it to post natal period.


Condition Intervention
Cord Blood Amino Acid Profile Fetal Amino Acid Profile in Different Gestational Ages Infant Amino Acid Profile at Day 3 and Discharge Other: Blood sample on Guthrie paper from cord blood, and day 3 of life and before discharge

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 180
Study Start Date: July 2010
Groups/Cohorts Assigned Interventions
Term and preterm newborn infants
5 infants of each gestational age of 24-42 weeks
Other: Blood sample on Guthrie paper from cord blood, and day 3 of life and before discharge
Mass spectroscopy on the blood sample that are taken as routine for the national inborn errors survey

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 6 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Term and preterm newborn infants
Criteria

Inclusion Criteria:

  • All new-born infants 5 of each gestational age

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01140698


Contacts
Contact: Leah Leibovitch, MD 972-52-6667325 leah.leibovitch@gmail.com

Locations
Israel
Sheba medical center Not yet recruiting
Ramat Gan, Israel, 52621
Contact: Leah Leibovitch, MD    972-52-6667325    leah.leibovitch@gmail.com   
Principal Investigator: Leah Leibovitch, MD         
Sponsors and Collaborators
Sheba Medical Center
  More Information

Responsible Party: Leah Leibovitch, Shaba Medical Center
ClinicalTrials.gov Identifier: NCT01140698     History of Changes
Other Study ID Numbers: SHEBA-10-7895-LL-SMC
First Submitted: June 8, 2010
First Posted: June 9, 2010
Last Update Posted: June 9, 2010
Last Verified: June 2010


To Top